Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers S > Headlines for Spectrum Pharmaceuticals, Inc. > News item |
Biotechnology Value Fund reports passive stake of 5.83% in Spectrum Pharmaceuticals
By E. Janene Geiss
Philadelphia, Dec. 15 - Biotechnology Value Fund, LP reported an equity investment of 5.83% in Spectrum Pharmaceuticals, Inc. as of Dec. 4, according to an SC 13G filing.
The holdings represent a passive stake of 1,853,000 shares.
Spectrum is an Irvine, Calif., biopharmaceutical company that acquires, develops and commercializes specialty pharmaceuticals.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.